[ Back ]   [ More News ]   [ Home ]
Protolabs Reports Record Revenue and Net Income for Third Quarter 2018

Record Quarterly Revenue of $115.4 million, an increase of 31% over Q3 2017

Record Quarterly Net Income of $20.9 million, an increase of 58% over Q3 2017

MAPLE PLAIN, Minn. — (BUSINESS WIRE) — October 25, 2018 — Proto Labs, Inc. (NYSE: PRLB), a leading online and technology-enabled, quick-turn, on-demand manufacturer, today announced financial results for the third quarter ended September 30, 2018.

Third Quarter 2018 Highlights include:

“We are pleased to deliver another quarter with over 30 percent growth,” said Vicki Holt, President and Chief Executive Officer. “Protolabs again demonstrated strong performance across all of our geographies and in each of our services.”

Additional Third Quarter 2018 Highlights include:

“As a result of continued strong operations and growth in each of our individual service offerings, we are becoming more of a total solution for some of our customers. The majority of our top customers have utilized every one of our core services in 2018. With our unique ability to deliver parts at unprecedented speed, we are helping more customers deliver their products to market faster and in new ways,” concluded Holt.

Non-GAAP Financial Measures

The company has included non-GAAP revenue growth that excludes the impact of changes in foreign currency exchange rates. Management believes these metrics are useful in evaluating the underlying business trends and ongoing operating performance of the company.

The company has included non-GAAP operating margin, adjusted for stock-based compensation expense and amortization expense (collectively, “non-GAAP operating margin”), in this press release to provide investors with additional information regarding the company’s financial results.

The company has included non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized foreign currency activity, disposal of businesses and legal settlement (collectively, “non-GAAP net income”), in this press release to provide investors with additional information regarding the company’s financial results.

The company has provided below reconciliations of GAAP to non-GAAP net income, operating margin and revenues, the most directly comparable measures calculated and presented in accordance with GAAP. These non-GAAP measures are used by the company’s management and board of directors to understand and evaluate operating performance and trends and provide useful measures for period-to-period comparisons of the company’s business. Accordingly, the company believes that these non-GAAP measures provide useful information to investors and others in understanding and evaluating operating results in the same manner as our management and board of directors.

Conference Call

The company has scheduled a conference call to discuss its third quarter 2018 financial results today, October 25, 2018 at 8:30 a.m. ET. To access the call in the U.S. please dial 877-709-8150 or outside the U.S. dial 201-689-8354 at least five minutes prior to the 8:30 a.m. start time. No participant code is required. A simultaneous webcast of the call will be available via the investor relations section of the Protolabs website and the following link: https://edge.media-server.com/m6/p/ep72okh4. A replay will be available for 14 days following the call on the investor relations section of the Protolabs website.

About Protolabs

Protolabs is the world's fastest digital manufacturing source for rapid prototyping and on-demand production. The technology-enabled company produces custom parts and assemblies in as fast as one day with automated 3D printing, CNC machining, sheet metal fabrication, and injection molding processes. Its digital approach to manufacturing enables accelerated time to market, reduces development and production costs, and minimizes risk throughout the product life cycle. Visit protolabs.com for more information.

Forward-Looking Statements

Statements contained in this press release regarding matters that are not historical or current facts are “forward-looking statements” within the meaning of The Private Securities Litigation Reform Act of 1995. These statements involve known and unknown risks, uncertainties and other factors which may cause the results of Protolabs to be materially different than those expressed or implied in such statements. Certain of these risk factors and others are described in the “Risk Factors” section within reports filed with the SEC. Other unknown or unpredictable factors also could have material adverse effects on Protolabs’ future results. The forward-looking statements included in this press release are made only as of the date hereof. Protolabs cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, Protolabs expressly disclaims any intent or obligation to update any forward-looking statements to reflect subsequent events or circumstances.

 
Proto Labs, Inc.
Condensed Consolidated Balance Sheets
(In thousands)
 
       
September 30, December 31,
2018 2017
(Unaudited)
Assets
Current assets
Cash and cash equivalents $ 62,593 $ 36,707
Short-term marketable securities 57,561 57,424
Accounts receivable, net 62,131 51,503
Inventory 9,608 11,271
Income taxes receivable - 1,832
Other current assets   8,639   6,267
Total current assets 200,532 165,004
 
Property and equipment, net 210,053 166,440
Long-term marketable securities 33,224 37,034
Goodwill 128,752 128,504
Other intangible assets, net 19,713 19,084
Other long-term assets   3,590   2,672
Total assets $ 595,864 $ 518,738
 
Liabilities and shareholders' equity
Current liabilities
Accounts payable $ 17,300 $ 15,876
Accrued compensation 14,462 12,100
Accrued liabilities and other 14,843 8,408
Short-term debt obligations - 5,000
Income taxes payable   2,763   2,371
Total current liabilities 49,368 43,755
 
Long-term income taxes payable 2,181 2,181
Long-term deferred tax liabilities 8,732 6,966
Other long-term liabilities 4,377 4,621
 
Shareholders' equity   531,206   461,215
Total liabilities and shareholders' equity $ 595,864 $ 518,738
 
 
               
Proto Labs, Inc.
Condensed Consolidated Statements of Operations
(In thousands, except share and per share amounts)
(Unaudited)
 
Three Months Ended Nine Months Ended
September 30, September 30,

2018

2017

2018

2017

Revenue
Injection Molding $ 53,681 $ 49,480 $ 156,610 $ 144,187
CNC Machining 40,845 27,166 115,364 73,318
3D Printing 13,845 11,102 39,418 32,061
Sheet Metal 6,452 - 19,002 -
Other   607   357   2,433   746
Total revenue 115,430 88,105 332,827 250,312
 
Cost of revenue   53,027   38,793   153,303   109,358
Gross profit 62,403 49,312 179,524 140,954
 
Operating expenses
Marketing and sales 16,818 13,846 50,947 41,463
Research and development 7,458 5,877 21,155 17,784
General and administrative   13,096   10,222   38,679   28,256
Total operating expenses   37,372   29,945   110,781   87,503
Income from operations 25,031 19,367 68,743 53,451
Other income, net   390   291   1,376   1,779
Income before income taxes 25,421 19,658 70,119 55,230
Provision for income taxes   4,484   6,438   12,817   17,724
Net income $ 20,937 $ 13,220 $ 57,302 $ 37,506
 
Net income per share:
Basic $ 0.77 $ 0.50 $ 2.13 $ 1.41
Diluted $ 0.77 $ 0.49 $ 2.10 $ 1.40
 
Shares used to compute net income per share:
Basic 27,038,585 26,617,349 26,963,205 26,600,174
Diluted 27,337,886 26,802,034 27,268,311 26,716,553
                                 
 
 
Proto Labs, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands)
(Unaudited)
       
Nine Months Ended
September 30,
2018 2017
Operating activities
Net income $ 57,302 $ 37,506
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization 19,520 13,539
Stock-based compensation expense 7,986 6,159
Deferred taxes 1,770 715
Gain on sale of businesses (671 ) -
Amortization of held-to-maturity securities 336 851
Other 160 21
Changes in operating assets and liabilities   (1,441 )   209  
Net cash provided by operating activities   84,962     59,000  
 
Investing activities
Purchases of property, equipment and other capital assets (61,898 ) (24,164 )
Cash used for acquisitions, net of cash acquired (90 ) -
Proceeds from sale of businesses 284 -
Purchases of marketable securities (41,384 ) (20,037 )
Proceeds from maturities of marketable securities 44,721 34,090
Purchases of other assets and investments   (126 )   (514 )
Net cash used in investing activities   (58,493 )   (10,625 )
 
Financing activities
Payments on debt (5,000 ) -
Proceeds from exercises of stock options and other 5,248 5,749
Repurchases of common stock   -     (4,410 )
Net cash provided by financing activities   248     1,339  
Effect of exchange rate changes on cash and cash equivalents   (831 )   774  
Net increase in cash and cash equivalents 25,886 50,488
Cash and cash equivalents, beginning of period   36,707     68,795  
Cash and cash equivalents, end of period $ 62,593   $ 119,283  
                     
 
               
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Net Income per Share
(In thousands, except share and per share amounts)
(Unaudited)
 
Three Months Ended Nine Months Ended
September 30, September 30,

2018

2017

2018

2017

Non-GAAP net income, adjusted for stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, disposal of businesses and legal settlement

GAAP net income $ 20,937 $ 13,220 $ 57,302 $ 37,506
Add back:
Stock-based compensation expense 2,952 2,201 7,986 6,159
Amortization expense 808 106 2,371 394
Unrealized loss (gain) on foreign currency (101 ) 266 147 (83 )
Disposal of businesses - - (671 ) -
Legal settlement   -     -     -     (417 )
Total adjustments 1 3,659 2,573 9,833 6,053
Income tax benefits on adjustments 2   (1,213 )   (747 )   (4,574 )   (1,824 )
Non-GAAP net income $ 23,383   $ 15,046   $ 62,561   $ 41,735  
 
 
Non-GAAP net income per share:
Basic $ 0.86   $ 0.57   $ 2.32   $ 1.57  
Diluted $ 0.86   $ 0.56   $ 2.29   $ 1.56  
 
Shares used to compute non-GAAP net income per share:
Basic 27,038,585 26,617,349 26,963,205 26,600,174
Diluted 27,337,886 26,802,034 27,268,311 26,716,553
 
 
1 Stock-based compensation expense, amortization expense, unrealized loss (gain) on foreign currency, disposal of businesses and legal settlement were included in the following GAAP consolidated statement of operations categories:
 
Three Months Ended Nine Months Ended
September 30, September 30,

2018

2017

2018

2017

 
Cost of revenue $ 446 $ 263 $ 1,096 $ 698
 
Marketing and sales 560 417 1,380 1,024
Research and development 419 295 1,109 796
General and administrative   2,335     1,332     6,772     4,035  
Total operating expenses 3,314 2,044 9,261 5,855
 
Other income, net   (101 )   266     (524 )   (500 )
Total adjustments $ 3,659   $ 2,573   $ 9,833   $ 6,053  
 
2 For the three- and nine-months ended September 30, 2018 and 2017, income tax effects were calculated using the effective tax rate for the relevant jurisdictions. Our non-GAAP tax rates differ from our GAAP tax rates due primarily to the mix of activity incurred in domestic and foreign tax jurisdictions and removing effective tax rate benefits from stock-based compensation activity in the quarter.
 
 
               
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin
(In thousands)
(Unaudited)
 
Three Months Ended Nine Months Ended
September 30, September 30,

2018

2017

2018

2017

Revenue $ 115,430 $ 88,105 $ 332,827 $ 250,312
Income from operations   25,031   19,367   68,743   53,451
GAAP operating margin 21.7% 22.0% 20.7% 21.4%
Add back:
Stock-based compensation expense 2,952 2,201 7,986 6,159
Amortization expense   808   106   2,371   394
Total adjustments   3,760   2,307   10,357   6,553

Non-GAAP income from operations adjusted for stock-based compensation expense and amortization expense

$ 28,791 $ 21,674 $ 79,100 $ 60,004
Non-GAAP operating margin 24.9% 24.6% 23.8% 24.0%
                                 
 
                       
Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth
(In thousands)
(Unaudited)
 

Three Months Ended
September 30, 2018

Three Months
Ended
September 30,
2017

%

% Change
Constant

GAAP Adjustments1 Non-GAAP GAAP

Change2

Currencies3
Revenues
United States $ 90,732 $ - $ 90,732

$

67,490 34.4 % 34.4 %
Europe 21,273 162 21,435 18,094 17.6 % 18.5 %
Japan   3,425   16     3,441   2,521 35.9 % 36.5 %
Total Revenue $ 115,430 $ 178   $ 115,608 $ 88,105 31.0 % 31.2 %
                                     
 

Nine Months Ended
September 30, 2018

Nine Months
Ended
September 30,
2017

 

%

% Change
Constant

GAAP Adjustments1 Non-GAAP GAAP

Change2

Currencies3
Revenues
United States $ 261,253 $ - $ 261,253 $ 191,019 36.8 % 36.8 %
Europe 61,431 (3,825 ) 57,606 51,224 19.9 % 12.5 %
Japan   10,143   (211 )   9,932   8,069 25.7 % 23.1 %
Total Revenue $ 332,827 $ (4,036 ) $ 328,791 $ 250,312 33.0 % 31.4 %
 
1 Revenue growth for the three- and nine-month periods ended September 30, 2018 has been recalculated using 2017 foreign currency exchange rates in effect during comparable periods to provide information useful in evaluating the underlying business trends excluding the impact of changes in foreign currency exchange rates.
 
2 This column presents the percentage change from GAAP revenue growth for the three- and nine-month periods ended September 30, 2017 to GAAP revenue growth for the three- and nine-month periods ended September 30, 2018.
 
3 This column presents the percentage change from GAAP revenue growth for the three- and nine-month periods ended September 30, 2017 (calculated using the foreign currency exchange rates in effect during that period) to non-GAAP revenue growth for the three- and nine-month periods ended September 30, 2018 (as recalculated using the foreign currency exchange rates in effect during the three- and nine-month periods ended September 30, 2017) in order to provide a constant currency comparison.
 
 
 
Proto Labs, Inc.
Product Developer Information
(Unaudited)
               
Three Months Ended Nine Months Ended
September 30, September 30,
2018 2017 2018 2017
Unique product developers and engineers served 20,792 16,909 38,823 31,307
                         
 



Contact:

Investor Relations Contact:
Proto Labs, Inc.
Dan Schumacher, 763-479-7240
Director of Investor Relations
Email Contact
or
Media Contact:
Padilla for Protolabs
Tim Nelson, 612-455-1789
Email Contact